Juan Carlos Garcia-Pagan
Overview
Explore the profile of Juan Carlos Garcia-Pagan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
233
Citations
7853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez-Aldehuelo R, Villanueva C, Genesca J, Garcia-Pagan J, Castillo E, Calleja J, et al.
JHEP Rep
. 2025 Jan;
7(2):101231.
PMID: 39850960
Background & Aims: Systemic inflammation is a driver of decompensation in cirrhosis with unclear relevance in the compensated stage. We evaluated inflammation and bacterial translocation markers in compensated cirrhosis and...
2.
Fortea J, Alvarado-Tapias E, Simbrunner B, Ezcurra I, Hernandez-Gea V, Aracil C, et al.
J Hepatol
. 2024 Dec;
PMID: 39701300
Background & Aims: Data on the effectiveness of classical non-selective beta-blockers (cNSBBs, i.e., propranolol and nadolol) vs. carvedilol in patients with cirrhosis are scarce. In the present study, we aimed...
3.
Rautou P, Giudicelli-Lett H, Magaz M, Garcia-Pagan J
J Hepatol
. 2024 Nov;
PMID: 39608460
No abstract available.
4.
Blasi A, Calvo A, Mellado R, Torrente M, Turon F, Garcia-Pagan J, et al.
Res Pract Thromb Haemost
. 2024 Nov;
8(7):102583.
PMID: 39552771
No abstract available.
5.
Rovira J, Ramirez-Bajo M, Banon-Maneus E, Ventura-Aguiar P, Arias-Guillen M, Romano-Andrioni B, et al.
Nutrients
. 2024 Nov;
16(21).
PMID: 39519573
Background: Cardiovascular disease (CVD) remains the most common cause of mortality in chronic kidney disease (CKD) patients. Several studies suggest that the Mediterranean diet reduces the risk of CVD due...
6.
Turon F, Shalaby S, Garcia-Pagan J, Hernandez-Gea V
Liver Transpl
. 2024 Nov;
PMID: 39508745
Portal vein thrombosis (PVT) is a frequent event among patients with advanced liver disease, with a prevalence reaching up to 26% in those awaiting liver transplantation (LT). Extensive thrombosis affecting...
7.
Olivas P, Soler-Perromat A, Tellez L, Carrion J, Alvarado-Tapias E, Ferrusquia-Acosta J, et al.
JHEP Rep
. 2024 Oct;
6(10):101170.
PMID: 39430576
Background & Aims: Etiologic factor removal (ER) drives recompensation and improves portal hypertension in cirrhosis. Esophageal varices (EV) and portosystemic shunts (PSS) have been found in patients despite hepatic venous...
8.
Shalaby S, Nicoara-Farcau O, Perez-Campuzano V, Olivas P, Torres S, Garcia-Pagan J, et al.
J Clin Med
. 2024 Oct;
13(19).
PMID: 39407741
Acute variceal bleeding in cirrhosis represents a critical clinical event that significantly impacts patient prognosis, with mortality rates increasing further after a second episode. This underscores the need for immediate...
9.
Magaz M, Giudicelli-Lett H, Abraldes J, Nicoara-Farcau O, Turon F, Rajoriya N, et al.
J Hepatol
. 2024 Aug;
82(1):72-83.
PMID: 39181213
Background & Aims: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine...
10.
Wang G, Zhang F, Ojeda A, Shalaby S, Hernandez-Gea V, Garcia-Pagan J
Dig Liver Dis
. 2024 Jun;
56(12):1980-1988.
PMID: 38853090
Transjugular intrahepatic portosystemic shunt (TIPS), a highly effective procedure reducing portal hypertension, has been in use for over seven decades and is now a cornerstone in managing portal hypertension-related complications...